MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1126/scitranslmed.adh1334

Медицинская библиотека · Science translational medicine · 2024

mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria.

Gurung Sonam, Timmermand Oskar Vilhelmsson, Perocheau Dany, Gil-Martinez Ana Luisa, Minnion Magdalena, Touramanidou Loukia, Fang Sherry, Messina Martina, Khalil Youssef, Spiewak Justyna, Barber Abigail R, Edwards Richard S, Pinto Patricia Lipari, Finn Patrick F, Cavedon Alex, Siddiqui Summar, Rice Lisa, Martini Paolo G V, Ridout Deborah, Heywood Wendy, Hargreaves Ian, Heales Simon, Mills Philippa B, Waddington Simon N, Gissen Paul, Eaton Simon, Ryten Mina, Feelisch Martin, Frassetto Andrea, Witney Timothy H, Baruteau Julien

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The urea cycle enzyme argininosuccinate lyase (ASL) enables the clearance of neurotoxic ammonia and the biosynthesis of arginine. Patients with ASL deficiency present with argininosuccinic aciduria, an inherited metabolic disease with hyperammonemia and a systemic phenotype coinciding with neurocognitive impairment and chronic liver disease. Here, we describe the dysregulation of glutathione biosynthesis and upstream cysteine utilization in ASL-deficient patients and mice using targeted metabolomics and in vivo positron emission tomography (PET) imaging using (S)-4-(3-18F-fluoropropyl)-l-glutamate ([18F]FSPG). Up-regulation of cysteine metabolism contrasted with glutathione depletion and down-regulated antioxidant pathways. To assess hepatic glutathione dysregulation and liver disease, we present [18F]FSPG PET as a noninvasive diagnostic tool to monitor therapeutic response in argininosuccinic aciduria. Human hASL mRNA encapsulated in lipid nanoparticles improved glutathione metabolism and chronic liver disease. In addition, hASL mRNA therapy corrected and rescued the neonatal and adult Asl-deficient mouse phenotypes, respectively, enhancing ureagenesis. These findings provide mechanistic insights in liver glutathione metabolism and support clinical translation of mRNA therapy for argininosuccinic aciduria.

Для цитирования: Gurung Sonam, Timmermand Oskar Vilhelmsson, Perocheau Dany, Gil-Martinez Ana Luisa, Minnion Magdalena, Touramanidou Loukia, Fang Sherry, Messina Martina, Khalil Youssef, Spiewak Justyna, Barber Abigail R, Edwards Richard S, Pinto Patricia Lipari, Finn Patrick F, Cavedon Alex, Siddiqui Summar, Rice Lisa, Martini Paolo G V, Ridout Deborah, Heywood Wendy, Hargreaves Ian, Heales Simon, Mills Philippa B, Waddington Simon N, Gissen Paul, Eaton Simon, Ryten Mina, Feelisch Martin, Frassetto Andrea, Witney Timothy H, Baruteau Julien. mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria.. Science translational medicine. 2024. DOI: 10.1126/scitranslmed.adh1334.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.